Friday, February 11, 2022 5:37:53 PM
That's great advice and I do that with some of my stocks. Like BBI^G and some others but to be honest I am scared to death to do that with SLS and a few others I own. Not trying to spam anyone here fyi. And have done well with some. But over the last few years trading as I am learning I have seen a few Biotech stocks get FDA approval and seen stocks jump up 1000's percent in one day and have often wished I had been a part of one of those. I'm probably wrong but I feel like SLS has that potential after all the DD I have done on it. Especially with such a low float. Every dollar SLS goes up it will only raise the Market Cap 16 million $'s. I have 3 stocks that I am really excited about and scared to death of missing the big run up and SLS is one of those 3 ;). If I got caught up flipping, I would be soooo mad at myself lol. One stock I have held for over 4 years now and haven't flipped any. And believe me when I say I am a fool because I could have had so many free shares by now. Ugh, a lot of failures I have had over the short 5 years of my trading. But still it has been a wonderful learning experience and somehow, I am still way ahead of what I started out with. I am a minnow in an ocean of traders and my goal is to get to 1000 shares of SLS. I have 600 now and hopefully I can get there before GPS is FDA approved or before SLS is bought out by a HUGE pharma company. Either way I hope we all do well here and 2022 is our year. Best of luck to you harry crumb and have a great weekend :)
Recent SLS News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 08:07:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/12/2026 08:01:32 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 04/24/2026 08:11:56 PM
- Form ARS - Annual Report to Security Holders • Edgar (US Regulatory) • 04/23/2026 08:12:11 PM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 04/23/2026 08:10:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 04/23/2026 08:09:30 PM
- Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers • Edgar (US Regulatory) • 03/20/2026 09:01:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/19/2026 08:08:36 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 03/19/2026 08:00:44 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 08:06:12 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 03:34:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:35:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:33:13 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/09/2026 09:31:37 PM
- The $170B Survival Race: Why Big Pharma is Snapping Up Late-Stage Cancer Tech • GlobeNewswire Inc. • 01/08/2026 05:08:13 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2026 01:30:35 PM
- Precision's Payoff: Targeted Therapies Drive $131B Solid Tumor Market Surge • GlobeNewswire Inc. • 12/24/2025 11:00:00 AM
- Sellas Life Sciences rises after reporting encouraging AML clinical results • IH Market News • 12/08/2025 03:26:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:07:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 12/05/2025 09:05:13 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (US) • 12/04/2025 05:20:00 PM
- Blood Cancer Therapeutics Reach Critical Commercial and Clinical Inflection Points • PR Newswire (Canada) • 12/04/2025 05:20:00 PM
